Parkman Healthcare Partners LLC - ARCELLX INC ownership

ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 138 filers reported holding ARCELLX INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.9%.

Quarter-by-quarter ownership
Parkman Healthcare Partners LLC ownership history of ARCELLX INC
ValueSharesWeighting
Q3 2023$7,300,934
+18.3%
203,482
+4.2%
1.34%
+25.0%
Q2 2023$6,174,121
+35.7%
195,260
+32.2%
1.07%
+8.2%
Q1 2023$4,548,973
+21.3%
147,646
+21.9%
0.99%
-1.0%
Q4 2022$3,751,461
+42.9%
121,093
-13.4%
1.00%
+33.9%
Q3 2022$2,625,000
-18.4%
139,875
-21.4%
0.75%
-37.0%
Q2 2022$3,218,000178,0001.18%
Other shareholders
ARCELLX INC shareholders Q3 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 3,946,630$141,605,08472.57%
NEA Management Company, LLC 3,745,262$134,380,00110.38%
Paradigm Biocapital Advisors LP 2,953,122$105,958,0177.19%
Samsara BioCapital, LLC 613,921$22,027,4856.74%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,869,967$102,974,4165.56%
Perceptive Advisors 3,965,978$142,299,2914.75%
Cormorant Asset Management, LP 2,150,000$77,142,0004.50%
Affinity Asset Advisors, LLC 400,000$14,352,0004.04%
Novo Holdings A/S 1,075,000$38,571,0002.85%
Soleus Capital Management, L.P. 643,777$23,098,7192.13%
View complete list of ARCELLX INC shareholders